Zenas BioPharma (ZBIO) Revenue (2023 - 2025)
Zenas BioPharma's (ZBIO) quarterly Revenue came in at $10.0 million in Q1 2025, up 100.0% quarter-over-quarter from $5.0 million in Q4 2024.
Zenas BioPharma (ZBIO) Revenue (2023 - 2025) Analysis & Trends
Zenas BioPharma's Revenue history runs 3 years deep, the most recent figure standing at $10.0 million for Q1 2025.
- On a quarterly basis, Revenue changed N/A year-over-year to $10.0 million in Q1 2025; TTM through Dec 2025 was $10.0 million, a 100.0% increase from a year earlier, with the FY2025 full-year figure at $10.0 million, up 100.0% from the prior year.
- Revenue rose to $10.0 million in Q1 2025 per ZBIO's latest filing, from $5.0 million in the prior quarter.
- Across five years, Revenue topped out at $50.0 million in Q3 2023 and bottomed at $5.0 million in Q4 2024.
- The 3-year median for Revenue is $10.0 million (2025), against an average of $21.7 million.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.51 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.56 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Zenas BioPharma | 1.72 Bn | 1.72 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 10.00 Mn |
| Dec 31, 2024 | 5.00 Mn |
| Sep 30, 2023 | 50.00 Mn |